Journal of Pathology and Disease Biology

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +44 1518081136

Commentary - Journal of Pathology and Disease Biology (2023) Volume 7, Issue 5

Metabolic dysregulation in disease: Uncovering molecular links

Haiming Avila*

Department of Pathology, University of South Alabama, Alabama, United States

Corresponding Author:
Haiming Avila
Department of Pathology,
University of South Alabama,
United States

Received: 10-Jul-2023, Manuscript No. AAPDB-23-105431; Editor assigned: 13-Jul-2023, AAPDB-23-105431 (PQ); Reviewed: 28-Jul-2023, QC No. AAPDB-23-105431; Revised: 11-Sep-2023, Manuscript No. AAPDB-23-105431 (R); Published: 19-Sep-2023, DOI:10.35841/AAPDB.7.5.174

Citation: Avila H. Metabolic dysregulation in disease: Uncovering molecular links. J Pathol Dis Biol. 2023;7(5):1.

Visit for more related articles at Journal of Pathology and Disease Biology


Metabolism plays a fundamental role in maintaining cellular functions and overall homeostasis in the human body. Disruptions in metabolic processes can lead to profound consequences and contribute to the development of various diseases. Metabolic dysregulation has been implicated in conditions such as obesity, diabetes, cardiovascular diseases, and cancer. This article explores the intricate molecular links between metabolic dysregulation and disease development, shedding light on the underlying mechanisms and potential therapeutic strategies [1].

Metabolic dysregulation refers to the disturbance in the balance of metabolic processes, including energy production, nutrient utilization, and cellular signaling. Emerging evidence has established a strong connection between metabolic dysregulation and the pathogenesis of diseases. Perturbations in metabolic pathways can alter cellular functions, disrupt tissue homeostasis, and contribute to the development and progression of various diseases [2].

Obesity and metabolic syndrome are prime examples of diseases linked to metabolic dysregulation. Excessive caloric intake, sedentary lifestyles, and genetic predispositions contribute to metabolic imbalances that lead to obesity. The dysregulation of lipid metabolism, insulin resistance, and chronic low grade inflammation are interconnected molecular links that promote the development of obesity related complications, including type 2 diabetes, cardiovascular diseases, and non-alcoholic fatty liver disease [3].

Metabolic dysregulation also plays a critical role in the development of cancer. Tumor cells undergo metabolic reprogramming to sustain their high energy demands and rapid growth. Dysregulated metabolic pathways, such as increased glucose uptake (the Warburg effect), altered lipid metabolism, and dysregulated amino acid metabolism, provide cancer cells with the necessary building blocks for proliferation and survival. Targeting these metabolic vulnerabilities has emerged as a promising approach for cancer therapy [4].

Advancements in molecular biology and metabolomics have facilitated the exploration of the molecular links between metabolic dysregulation and disease. High-throughput technologies allow for the comprehensive analysis of metabolites, metabolic pathways, and regulatory factors. These approaches have revealed intricate molecular networks and key metabolic players involved in disease progression. Understanding these molecular links is crucial for the development of novel therapeutic strategies that target specific metabolic pathways or restore metabolic balance [5].


Metabolic dysregulation serves as a critical molecular link in the pathogenesis of various diseases. By uncovering the underlying molecular mechanisms, researchers can identify potential therapeutic targets for intervention. Modulating metabolic pathways, restoring metabolic balance, and promoting healthy lifestyles have the potential to prevent and treat diseases associated with metabolic dysregulation. Continued research in this field, combined with personalized approaches, holds great promise for improving patient outcomes and reducing the burden of metabolic diseases on global health.


Get the App